|
1
|
Gatta G, Capocaccia R, Botta L, Mallone S,
De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK,
Siesling S, et al: Burden and centralised treatment in Europe of
rare tumours: Results of RARECAREnet-a population-based study.
Lancet Oncol. 18:1022–1039. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Pinieux G, Karanian M, Le Loarer F, Le
Guellec S, Chabaud S, Terrier P, Bouvier C, Batistella M, Neuville
A, Robin YM, et al: Nationwide incidence of sarcomas and connective
tissue tumors of intermediate malignancy over four years using an
expert pathology review network. PLoS One. 16:e02469582021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Strauss SJ, Frezza AM, Abecassis N, Bajpai
J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, et
al: Bone sarcomas: Esmoeuracan-genturis-ernpaedcan clinical
practice guideline for diagnosis, treatment and follow-up. Ann
Oncol. 32:1520–1536. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Storey L, Fern LA, Martins A, Wells M,
Bennister L, Gerrand C, Onasanya M, Whelan JS, Windsor R, Woodford
J and Taylor RM: A critical review of the impact of sarcoma on
psychosocial wellbeing. Sarcoma. 2019:97308672019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li F, Zhang DB, Ma Y, Song Y and Duan XL:
Effects of combined sintilimab and chemotherapy on progression-free
survival and overall survival in osteosarcoma patients with
metastasis. Pak J Med Sci. 40:648–651. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng SH, Mbarak HS, Li YH, Ma C, Shang QL,
Chen Z, Bian DJ and Xiao EH: Neoadjuvant intra-arterial versus
intravenous chemotherapy in colorectal cancer. Medicine.
100:e283122021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kou F, Gao S, Liu S, Wang X, Chen H, Zhu
X, Guo J, Zhang X, Feng A and Liu B: Preliminary clinical efficacy
of iodine-125 seed implantation for the treatment of advanced
malignant lung tumors. J Cancer Res Ther. 15:1567–1573. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Jiang Y, Ji Z, Jiang P, Xu F,
Zhang Y, Zhang P, Guo F, Li X, Sun H, et al: Dosimetry, efficacy,
and safety of three-dimensional printing noncoplanar
template-assisted and CT-guided 125I seed implantation for
recurrent retroperitoneal lymphatic metastasis after external beam
radiotherapy. Brachytherapy. 19:380–388. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He S, Renne A, Argandykov D, Convissar D
and Lee J: Comparison of an emoji-based visual analog scale with a
numeric rating scale for pain assessment. JAMA. 328:208–209. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cates JMM: Comparison of the AJCC, MSTS,
and Modified Spanier Systems for Clinical and Pathologic Staging of
Osteosarcoma. Am J Surg Pathol. 41:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brierley JD and Wittekind C: TNM
Classification of Malignant Tumours. 8 edition. John Wiley &
Sons; Oxford: 2016
|
|
12
|
Jin Q, Xie X, Yao H, Wen L, Li H, Lv D,
Zeng Z, Wang Y, Zou C, Yin J, Huang G, Wang B, et al: Clinical
significance of the radiological relationship between the tumor and
the main blood vessels in Enneking IIB osteosarcoma of the
extremities. J Cancer. 11:3235–3245. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferrari S, Smeland S, Mercuri M, Bertoni
F, Longhi A, Ruggieri P, AlvegardAlvegard TA, Picci P, Capanna R,
Bernini G, et al: Neoadjuvant chemotherapy with high-dose
Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for
patients with localized osteosarcoma of the extremity: A joint
study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol.
23:8845–8852. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smeland S, Bielack SS, Whelan J, Bernstein
M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC,
Anninga J, et al: Survival and prognosis with osteosarcoma:
Outcomes in more than 2000 patients in the EURAMOS-1 (European and
American Osteosarcoma Study) cohort. Eur J Cancer. 109:36–50. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kallis M, Maloney C, Edelman M, Soffer S,
Symons M and Steinberg B: Abstract PR13: Surgical excision of the
primary tumor in osteosarcoma model results in enhanced metastatic
growth by modulating the lung immune microenvironment. Cancer Res.
80 (Suppl 1):PR13. 2020. View Article : Google Scholar
|
|
17
|
Niculescu ȘA, Grecu AF, Gheonea C and
Grecu DC: Limb salvage surgery in pediatric patients with
osteosarcoma. Curr Health Sci J. 50:360–367. 2024.PubMed/NCBI
|
|
18
|
Gaspar N, Venkatramani R, Hecker-Nolting
S, Melcon SG, Locatelli F, Bautista F, Longhi A, Lervat C,
Entz-Werle N, Casanova M, et al: Lenvatinib with etoposide plus
ifosfamide in patients with refractory or relapsed osteosarcoma
(ITCC-050): A multicentre, open-label, multicohort, phase 1/2
study. Lancet Oncol. 22:1312–1321. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liao L, Li X, Wei G, Lu Y, Wei S, Lin K
and Zhang F: Efficacy of transcatheter arterial chemoembolization
combined with radiotherapy for locally advanced hepatocellular
carcinoma. Am J Transl Res. 16:6935–6945. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao YW, Liu S, Qin H, Sun JB, Su M, Yu
GJ, Zhou J, Gao F, Wang RY, Zhao T and Zhao GS: Efficacy and safety
of CalliSpheres drug-eluting beads for bronchial arterial
chemoembolization for refractory non-small-cell lung cancer and its
impact on quality of life: A multicenter prospective study. Front
Oncol. 13:11109172023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Di X, Zhang H, Liu X, Zhao J, Gao Z, Yu H,
Su X, Liang Y and Wang J: A new technique for trans-perirectal
iodine-125 seed implantation in prostatic cancer guided by CT and
3D printed template: Two case reports. Front Oncol. 12:10319702022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang M, Lin X, Zhu L, Liu J, Ye X, Miu R
and Hu J: The efficacy and safety of percutaneous CT-guided
iodine-125 brachytherapy combined with standard chemotherapy and
brachytherapy alone for lung malignant nodule: A retrospective
comparative cohort study. J Thorac Dis. 16:573–580. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sui A, Song H, Yu H, Zhang H, Hu Q, Lei Y,
Zhang L and Wang J: Clinical application of iodine-125 seed
brachytherapy combined with anti-PD-1 antibodies in the treatment
of lung cancer. Clin Ther. 42:1612–1616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen C, Wang W, Yu Z, Tian S, Li Y and
Wang Y: Combination of computed tomography-guided iodine-125
brachytherapy and bronchial arterial chemoembolization for locally
advanced stage III non-small cell lung cancer after failure of
concurrent chemoradiotherapy. Lung Cancer. 146:290–296. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Katagiri H, Sugiyama H, Takahashi M,
Murata H, Wasa J, Hosaka S and Miyagi M: Osteosarcoma of the pelvis
treated successfully with repetitive intra-arterial chemotherapy
and radiation therapy: A report of a case with a 21-year follow-up.
J Orthop Sci. 20:568–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takaki H, Hirata Y, Ueshima E, Kodama H,
Matsumoto S, Wada R, Suzuki H, Nakasho K and Yamakado K: Hepatic
artery embolization enhances expression of programmed cell death 1
ligand 1 in an orthotopic rat hepatocellular carcinoma model: in
vivo and in vitro experimentation. J Vasc Interv Radiol.
31:1475–1482.e2. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chao Y, Wu CY, Kuo CY, Wang JP, Luo JC,
Kao CH, Lee RC, Lee WP and Li CP: Cytokines are associated with
postembolization fever and survival in hepatocellular carcinoma
patients receiving transcatheter arterial chemoembolization.
Hepatol Int. 7:883–892. 2013. View Article : Google Scholar : PubMed/NCBI
|
